ARCHIVES

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

This article is from The Cancer Letter archive.

Vol. 14 No. 43 | November 4, 1988

Download PDF Visit The Full Archive

Related Articles

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

CALGB Chairman Schilsky To Step Down After 15 Years Leading Cooperative Group.

February 1, 2008

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981

Mentholated Cigarettes Cause No More Lung Cancer, Deaths

March 25, 2011

Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse

February 5, 1988

ORI Finds Researcher Falsified Records

February 9, 1996